Overview

Crizotinib Continuation Clinical Study

Status:
Not yet recruiting

Trial end date:
2026-12-30

Target enrollment:

Participant gender:

Summary

The purpose of this continuation study is to provide continued access to crizotinib treatment for eligible participants from a current Pfizer sponsored crizotinib clinical study that is planned to close.

Phase:

Phase 4

Details

Lead Sponsor:

Pfizer

Treatments:

Crizotinib